How Much Did LifeBio Raise?
Funding & Key Investors

LifeBio has secured $3M in total capital, with its most recent funding round bringing in $2.9M through a major strategic investment. This significant backing underscores the company's progress in the healthtech and agetech sectors, particularly in its innovative approach to addressing critical issues like loneliness, depression, and Alzheimer's disease through reminiscence therapy and AI-powered platforms.

What is LifeBio?

LifeBio
SoftwareHealthcare SoftwareHealthcare Services

LifeBio is a pioneering healthtech and agetech company dedicated to enhancing the well-being of seniors and individuals facing cognitive challenges. The company leverages its proprietary LifeBio Memory platform, an AI-driven solution designed to facilitate the capture of life stories. This process not only helps individuals preserve their personal histories but also actively combats loneliness and depression, while simultaneously strengthening intergenerational connections. By focusing on reminiscence therapy and storytelling, LifeBio aims to improve cognitive function and emotional health for those affected by conditions such as Alzheimer's disease.

How much funding has LifeBio raised?

LifeBio has raised a total of $3M across 2 funding rounds:

2021

Debt

$135K

2025

Grant

$2.9M

Debt (2021): $135K with participation from PPP

Grant (2025): $2.9M led by National Institute on Aging

Key Investors in LifeBio

PPP

Public-Private Partnership

National Institute on Aging

The National Institute on Aging (NIA) is a leading federal research institute under the National Institutes of Health (NIH) that focuses on aging, Alzheimer's disease, and related dementias. It provides health information and resources for healthy aging, as well as funding opportunities for research in these areas. NIA aims to support health care professionals and researchers through training, grants, and data sharing resources. Its intended clients include older adults, caregivers, and health care professionals seeking to improve health outcomes related to aging.

What's next for LifeBio?

The substantial enterprise-level funding and recent strategic investment position LifeBio for accelerated growth and expanded market reach. This capital infusion is expected to fuel further development of its AI-powered platform, enhance its therapeutic offerings, and support broader adoption across healthcare facilities, senior living communities, and individual users. The company's focus on a growing demographic and a critical unmet need in elder care suggests a strong trajectory for future innovation and impact in the agetech and healthtech industries.

See full LifeBio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Enterprise Resource Planning (ERP)SoftwareBusiness Intelligence (BI) Software
Content & Collaboration SoftwareSoftwareEducationTraining
Financial SoftwareSoftwareInsuranceMobile App Development
Enterprise Resource Planning (ERP)Software

Frequently Asked Questions Regarding LifeBio Financial Insights

What are the most recent funding rounds that LifeBio has completed, and what were the funding rounds?
LifeBio has recently completed 2 funding rounds: Grant on Oct 3, 2025, Debt on Feb 2, 2021.
What is the total amount of funding LifeBio has raised to date?
LifeBio has raised a total of $3M in funding to date.
How many funding rounds has LifeBio completed?
LifeBio has completed 2 funding rounds.
How much funding did LifeBio raise in its most recent funding round?
LifeBio raised $2.9M in its most recent funding round.
Who are the lead investors in LifeBio's latest funding round?
The lead investor in LifeBio's latest funding round was National Institute on Aging. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in LifeBio's history?
The largest funding round in LifeBio's history was $2.9M.
See more information about LifeBio